Non-Hodgkin lymphoma survival statistics

This page presents non-Hodgkin lymphoma survival statistics including one, five and ten year survival rates, and survival rates in EU countries.

One, five and ten year survival rates

Non-Hodgkin lymphoma survival rates in EU countries

There have been significant improvements in one-, five- and ten-year survival from NHL over the past 30 years. For patients diagnosed with NHL in England and Wales in the early 1970s the five-year survival rate was around 30%, but for patients diagnosed in the late 1990s it was around 50% (Figure 3.1 ). 1 Survival rates are consistently higher in women than men.

Figure 3.1: One-, Five- and Ten-year relative survival for adults diagnosed with NHL in England and Wales during 1971-1995 and followed up to the end of 2001, and period survival estimates for patients alive with a diagnosis at some point during 2000-01

Download this chart (21.5KB)

A recent analysis showed that ten year relative survival rates for patients diagnosed with non-Hodgkin's lymphoma in England and Wales have doubled over the last forty years. Around half of patients (50.8%) are now predicted to survive their disease for at least ten years or more, compared to a fifth (21.8%) in the early 1970s. 4

Survival rates for NHL vary significantly by age, the five-year survival rate for those diagnosed aged 15-44 is 65%, while for those aged 65-74 it is 37% and those aged 85+ it is 13%. 2

The age-standardised relative five-year survival rates for male patients diagnosed with NHL 1990-1994 for the European countries participating in the EUROCARE 3 project are shown in Figure 3.2. 3 Survival rates in Wales and Scotland are significantly lower than the European average but rates in England are not significantly different.

Figure 3.2: Age-standardised relative five-year survival for men diagnosed with NHL 1990-1994, selected European countries